Join host Chase Hendrickson, MD, from Vanderbilt University Medical Center, in a discussion recorded in front of an audience at ENDO 2024 in Boston. He talks about a recent article in The Journal of Clinical Endocrinology & Metabolism with Amal Shibli-Rahhal, MD, from University of Iowa Carver College of Medicine, and guest expert Ghada El-Hajj Fuleihan, MD, from the American University of Beirut, along with four fellows who submitted questions ahead of time. The article featured this month, by Bauer et al, was first published online in JCEM in January 2024: “Bisphosphonate Use and Risk of Atypical Femoral Fractures: A Danish Case-Cohort Study With Blinded Radiographic Review.” Show notes can be found at https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series/efl050-bisphosphonates-and-atypical-femoral-fractures — podcast home page: https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related